By Professor Edwin Philip Enfield Kirk

Preprints

Trivellin G; Sánchez-Gaya V; Grasso A; Pasińska M; Stratakis CA; Milnes D; Kirk EP; Beckers A; Lania AG; Pétrossians P; Rada-Iglesias A; Franke M; Daly AF, 2025, Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE., http://dx.doi.org/10.1101/2025.06.27.25329768

Davidson S; Shibata Y; Collard S; Laohamonthonku P; Kong K; Sun J; Li MWY; Russell C; van Beek A; Kirk EP; Walsh R; Gray PE; Komander D; Masters SL, 2023, Dominant negative OTULIN Related Autoinflammatory Syndrome, http://dx.doi.org/10.1101/2023.03.24.23287549

Marjaneh MM; Kirk E; Patrick R; Alankerage D; Humphreys D; Del Monte-Nieto G; Cornejo-Paramo P; Janbandhu V; Doan T; Dunwoodie S; Wong E; Moran C; Martin ICA; Thomson P; Harvey R, 2022, Quantitative trait and transcriptome analysis of genetic complexity underpinning cardiac interatrial septation in mice using an advanced intercross line, http://dx.doi.org/10.1101/2022.10.31.514499

Freeman L; Kirk E; Scully JL; Delatycki M, 2022, Views of healthcare professionals on the inclusion of genes associated with non-syndromic hearing loss in reproductive genetic carrier screening, http://dx.doi.org/10.21203/rs.3.rs-1726721/v1

Back to profile page